Everything about api in pharmaceutical manufacturing
“The current scenario has uncovered some structural weaknesses in the EU’s medicines source chain and also a superior dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that supply chain concerns be resolved in an EU pharmaceuti